You can buy or sell GTHX and other stocks, options, ETFs, and crypto commission-free!
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. Read More The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.
Research Triangle Park, North Carolina
52 Week High
52 Week Low
— per share
Expected May 7, After Hours